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Cell fateCell-death and -survival decisions are critically controlled by intracellular Ca2+ homeostasis and dynamics at the
level of the endoplasmic reticulum (ER). Inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) play a pivotal role in
these processes by mediating Ca2+ ﬂux from the ER into the cytosol and mitochondria. Hence, it is clear that
many pro-survival and pro-death signaling pathways and proteins affect Ca2+ signaling by directly targeting
IP3R channels, which can happen in an IP3R-isoform-dependent manner. In this review, we will focus on how
the different IP3R isoforms (IP3R1, IP3R2 and IP3R3) control cell death and survival. First, wewill present an over-
viewof the isoform-speciﬁc regulation of IP3Rs by cellular factors like IP3, Ca2+, Ca2+-bindingproteins, adenosine
triphosphate (ATP), thiol modiﬁcation, phosphorylation and interacting proteins, and of IP3R-isoform speciﬁc
expression patterns. Second, we will discuss the role of the ER as a Ca2+ store in cell death and survival and
how IP3Rs and pro-survival/pro-death proteins can modulate the basal ER Ca2+ leak. Third, we will review the
regulation of the Ca2+-ﬂux properties of the IP3R isoforms by the ER-resident and by the cytoplasmic proteins
involved in cell death and survival as well as by redox regulation. Hence, we aim to highlight the speciﬁc roles
of the various IP3R isoforms in cell-death and -survival signaling. This article is part of a Special Issue entitled: Cal-
cium signaling in health and disease. Guest Editors: Geert Bultynck, Jacques Haiech, ClausW. Heizmann, Joachim
Krebs, and Marc Moreau.
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The IP3R is the most ubiquitous intracellular Ca2+ channel and is
represented in vertebrates by three different isoforms (IP3R1, IP3R2 and
IP3R3) with 60–80% homology in their amino acid (a.a.) sequences.
They are encodedbydifferent genes and further isoformdiversity is intro-
duced by the existence of alternative splice forms [1,2]. IP3R1 has three
splice sites, namely S1, S2 (below we will refer with S2− to the short
peripheral form and with S2+ to the long neuronal form) and S3. Also
for IP3R2 and the invertebrate isoforms, splice variantswere found (for re-
view see [2]). IP3Rs exist as tetramers and evidence for an additional level
of channel diversity, generated by heterotetrameric interactions among
different isoforms, came from co-immunoprecipitation experiments [3,
4] and from cross-linking studies [5]. The functional consequences of
heterotetramer formation were recently explored by assembling IP3Rs
from concatenated homo- and heteromeric subunits [6]. Dimeric con-
structs were expressed in DT40 triple knock-out (DT40-TKO) cells, an
IP3R null cell line. IP3Rs formed from concatenated dimers were found
to be functional and were studied using “on-nucleus” patch clamp. It
was found that heterotetramers do not simply behave as a blend of the
constitutive subunits. Notably, the activity of channels formed from
concatenated IP3R1 and IP3R2 was dominated by IP3R2 [6]. The general
domain structure of the IP3Rs has been determined and revealed two re-
gions of high homology between the subtypes: the N-terminal region
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domain and the determinants for tetramer formation [10,11]. The inter-
vening domain (~1700 a.a.) exhibits more sequence variability between
subtypes. This region is named the central, modulatory or coupling
domain and it contains interaction sites for many intracellular regulators
and interacting proteins [1,2,4,12–15]. By far the largest amount of
information about regulatory mechanisms is available for IP3R1, while
the other subtypes are less extensively documented. Mutational analysis
and expression of mutant isoforms in DT40-TKO cells yielded direct
information about isoform speciﬁcity in basic structure and regula-
tion [13]. The basic regulators of the IP3R are the free Ca2+ concen-
tration in the cytosol and in the ER ([Ca2+]cyt and [Ca2+]ER,
respectively), ATP, thiol modiﬁcation, and phosphorylation by protein
kinases. Furthermore, there is an increasing number of documented in-
teractions with regulatory proteins, including several proteins directly
involved in cell-fate regulation.
In this reviewwewill give an overview of the role of the IP3R in cell-
fate decisions, with a particular focus on the speciﬁc roles of IP3R iso-
forms. First, we will review the best documented cases of differential
regulation of the three isoforms by general cellular regulators
(Section 2). Following this, a more detailed description of the differen-
tial regulation by luminal and cytoplasmic interactors involved in
controlling cell death or survival will be given in Sections 3, 4 and 5.
2. Properties and expression patterns of the IP3R isoforms
2.1. Differential properties of IP3R isoforms
2.1.1. Activation by IP3
It was found that soluble monomeric proteins representing the N-
terminal 788 residues of the IP3Rs still retained IP3-binding properties [7,
8,16,17]. Deletion analysis revealed that the region encompassing resi-
dues 226–576 in IP3R1 represents the IP3-binding core, whereas the re-
gion containing residues 1–225 functions as a suppressor of IP3 binding
(Fig. 1) [9,18]. Crystal structures of both domains of mouse IP3R1 have
been published [19]. The N-terminal 604 residues from the three iso-
forms exhibited IP3-binding afﬁnities, that are close to the intrinsic
values found for the full-size receptors [20–23]. The relative afﬁnities
were IP3R2 N IP3R1 N IP3R3,with amore than 10-fold difference between
IP3R2 and IP3R3. The binding cores of the three isoforms appeared to
have a similar afﬁnity for IP3 and the suppressor domainwas responsible
for isoform-speciﬁc ﬁne tuning of this afﬁnity [21]. Deletion of the sup-
pressor domain resulted in a signiﬁcant increase in the IP3-binding afﬁn-
ity [9], but abolished the channel activity of the IP3R [24,25]. The
suppressor domain is also directly involved in linking ligand binding to
channel gating as was already suggested by earlier biochemical studies
[24,26]. From these early studies, the interaction was proposed to occur
between different subunits linking the N-terminus of one subunit to
the cytoplasmic loop connecting transmembrane helices 4 and 5 (M4–
M5 linker) of an adjacent subunit [27]. Compelling evidence for a critical
role of the suppressor domain in channel gating aswell as in determining
IP3 sensitivity, was obtained from mutational and structural data for
IP3R1 and IP3R3 [28,29]. The crystal structure of the suppressor domain
of IP3R3 has been determined [28] and the suppressor region appeared
to be structurally and functionally similar for the different isoforms. In
vitro evidence for a direct interaction between the suppressor domain
and the M4-M5 linker was obtained, mainly from pull-down experi-
ments with the isolated N-terminus [26] or the suppressor domain
[28]. Interestingly, mutations in the suppressor domain (like Y167 in
IP3R1 andW168 in IP3R3) that abolish IP3R-channel activity [29] also re-
duced the binding of the suppressor domain to the M4–M5 linker [28].
Yet, based on recent observations in an elegant study revealing that do-
mains critical for IP3R and ryanodine-receptor (RyR) channel function
are structurally and functionally conserved between both channels
[30], it was proposed that a direct interaction between the suppressor
domain and the M4–M5 linker is not very likely to be the mechanismfor gating the pore. This is supported by computational docking studies
placing the IP3-binding-domain structure into the cryo-electron micros-
copymap of IP3R1, thereby pointing towards an IP3R-activationmodel in
which additional cytosolic domains are likely involved in coupling the
N-terminal IP3-binding domain to the opening of the C-terminal
channel pore [30]. In any case, it is clear that both regions are essen-
tial for IP3R activation although the interaction may be indirect and
involving other domains [30,31].
2.1.2. Regulation by Ca2+
The regulation of the function of the IP3R is much more complex as
the IP3R is controlled by both IP3 and Ca2+ itself, which are operating
as co-agonists [32,33]. IP3-induced Ca2+ release (IICR) is typically regu-
lated by the [Ca2+]cyt in a biphasic way with a potentiation at a low
[Ca2+]cyt and an inhibition at higher concentrations [32,34–36]. A simi-
lar bell-shaped dependence on the [Ca2+]cyt was found for all three IP3R
subtypes but with clear isoform-speciﬁc characteristics regarding the
bell shape [23,37,38]. IP3 thereby dynamically changes the sensitivity
to [Ca2+]cyt [33,39]. Different mechanistic models were proposed to
explain the regulation of the IP3R by these two co-agonists [40,41]. In
these models IP3 functions as a regulator for either a Ca2+-activator
site [40], or as a regulator that decreases theCa2+ sensitivity of an inhib-
itory site [39]. Different types of IP3-dependent and IP3-independent
Ca2+-binding sites were proposed [41–43], but their exact locations
have not been identiﬁed. There is evidence for several direct interaction
sites for Ca2+, some of which are conserved amongst the various iso-
forms [44–46], and for a functional role of the E2100 residue in the
Ca2+ sensitivity [47,48]. However, the exact mechanistic role of these
sites is not clear. The effects of IP3 and of the [Ca2+]cyt on the bell-
shaped IP3R activation were evaluated using ﬂuorescence resonance
energy transfer (FRET) between ﬂuorescent proteins fused to the
N-terminus of individual IP3R subunits [49]. The FRET signal was
found to reﬂect IP3R activity and yielded the expected bell-shaped
dependence. A ﬁve-state model was proposed implementing a com-
petition response between the two ligands. In this model IP3 binding
prevents binding of Ca2+ to the inactivation sites and reciprocally,
Ca2+ binding to the inactivation sites prevents IP3 binding [49].
These data are also compatible with a single-particle analysis that
showed a structural transition induced by Ca2+ binding from a
square to a windmill form [50,51].
In addition to a regulation by the [Ca2+]cyt, the IP3R is also regulated
by the Ca2+ load in the lumen of the ER [52–58]. This regulation leads to
a much decreased sensitivity towards IP3 at low levels of store ﬁlling
(b30% ﬁlling), helping to prevent excessive ER depletion, which would
be detrimental for the cell [59]. There is good evidence from nuclear
patch experiments that this effect of the [Ca2+]ER is dependent on per-
meation of Ca2+ through the channel and the Ca2+ sensor may there-
fore be located at a cytosolic site [60]. In addition, as will be outlined
in the next sections, the [Ca2+]ER may also exert its effects via luminal
Ca2+-binding proteins that associate with the IP3R [61,62].
2.1.3. Regulation by Ca2+-binding proteins
The effects of Ca2+ may also be mediated by cytosolic Ca2+-binding
proteins such as calmodulin (CaM) and the neuronal Ca2+-binding pro-
tein 1 (CaBP1), which both have documented interaction sites with the
IP3R (Fig. 1). CaM can bind to a binding site located in the regulatory re-
gion of the receptor [63], to a split N-terminal site [64,65], and to a third
site created in IP3R1 by alternative splicing [66]. CaM inhibits the vari-
ous IP3R isoforms in a Ca2+-dependent way [67–71], but it is not the
Ca2+ sensor responsible for the biphasic Ca2+ regulation [64,72,
73]. A CaM-binding peptide derived from myosin light chain kinase,
which comprises a 1-8-14 CaM-binding sequence, was found to in-
hibit IICR [74] via all three IP3R subtypes [75]. A similar conserved
1-8-14 CaM-binding motif was recently identiﬁed in the suppressor
domain of IP3R1. Mimetic peptides speciﬁcally inhibit activation of
the IP3R by uncoupling the IP3-binding core from the suppressor
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result from a similar disruption of this interaction [76].
One part of the split N-terminal CaM-binding site of IP3R1 also binds
CaBP1 [77]. It was found that a much stronger interaction occurred
between the Ca2+-bound form of CaBP1 and the complete IP3-binding
domain (residues 1–587), which is in agreement with structural data
indicating that CaBP1 binding requires both the suppressor and the
ligand-binding core [78]. Recently, an NMR and docking analysis
suggested that CaBP1 forms an extended tetrameric turret attached
via the IP3R1 N-termini to the cytosolic vestibule of the pore [79]. The
hydrophobic residues within the C-lobe of CaBP1 that make the essen-
tial contacts with the IP3-binding core become exposed when CaBP1
binds Ca2+. CaBP1 is proposed to stabilize in this arrangement a closed
state of the IP3R1 channel by clamping the underlying subunits. CaBP1
would bind loosely to the neuronal IP3R1 at resting [Ca2+]cyt, whereas
Ca2+ passing through the pore can bind to CaBP1 thereby causing a
rapid feedback inhibition [79].2.1.4. Regulation by ATP
ATP and other adenine nucleotides were reported to increase the
IP3R activity at submillimolar concentrations, while higher concentra-
tions are inhibitory [80,81]. ATP modulates all three IP3R isoforms but
there are clear isoform-speciﬁc characteristics [82–84]. IP3R2 diverged
from the other isoforms as it appears to be modulated by ATP only at
submaximal IP3 concentrations [84,85]. Moreover, IP3R2 shows theFig. 1. Linear representation of the three IP3R isoforms and their regulatory mechanisms. The
three isoforms are indicated at the top. The ligand-binding domain is split into suppressor dom
C-terminal end. Numbering is based on the murine sequence. Selected regulatory mechanism
for CaM, CaBP1, Ca2+ and ATP) are indicated. Distinct differences between the three isoforms
of the IP3R. In this region also CaBP1 and CaM bind and regulate all three IP3R isoforms. IP3R1
N-terminal binding site for CaM in IP3R2 and IP3R3 is not determined. An additional CaM-bi
IP3R3. For IP3R1 at least 8 Ca2+-binding sites were documented. Two of these sites were shown
vealed similarities between the different isoforms at several of these locations. A conserved ATP
sites (ATPA and ATPC) were described on IP3R1.highest sensitivity of the three isoforms towardsmodulation by ATP [13,
86]. Interestingly, it was found in pancreatic acinar cells that IP3R2 was
ten times more sensitive than IP3R3 and the IP3R2 complement in these
cells largely determined the effects of metabolic stress on Ca2+ signal-
ing [87]. ATP binds to glycine-rich regions (Walker A motif) and the
IP3R sequence contains several of such motifs (Fig. 1) [2,15]. One site
called ATPB is common to all three isoforms, while two other sites,
ATPA and ATPC, the latter being formed upon S2− splicing, are unique
for IP3R1 [13]. There is good evidence that these sites in isolation can
bind ATP, but the presence of other sites could not be excluded [84,88,
89]. By systematic mutagenesis of the critical residues and expression
of themutant IP3Rs in DT40-TKO cells, the direct functional signiﬁcance
of these different ATP-binding sites has been investigated, leading to
some surprising ﬁndings [13,86]. Remarkably, neither the ATPA, nor
the ATPB site in IP3R1 appeared to be required for the modulation of
Ca2+ release by ATP [85]. It is possible that a novel ATP-binding se-
quencemediates this effect or that the effect depends on conformation-
al changes or on an accessory protein [13]. Similarly, disruption of the
conserved ATPB site in IP3R3 did not change themodulation of its activ-
ity by ATP [84]. A striking dependence on the ATPB site was found for
IP3R2, where this site was solely responsible for the functional effects
of ATP on Ca2+ signaling via B cell-receptor activation [84]. Also the
role of the ATPC site in the S2−-splice isoform of IP3R1was investigated
bymutational analysis [90]. Binding of ATP to the ATPC site was respon-
sible for a conformational change that made IP3R1 susceptible to phos-
phorylation by protein kinases including protein kinaseA (PKA), but notthree IP3R isoforms are depicted (grey). The three large functional domains present in all
ain and IP3-binding core. The transmembrane domains are indicated as black bars at the
s discussed in the text (e.g. phosphorylation sites for PKA and PKB/Akt, and binding sites
are shown on the ﬁgure. IP3 binding occurs at the N-terminally located IP3-binding core
contains a split binding site for CaM in the suppressor domain; the exact location of the
nding site is present in the regulatory domain of IP3R1 and IP3R2, but not in the one of
to be functionally conserved in the other two isoforms, although sequence alignment re-
-binding (ATPB) site is present in all three IP3R isoforms. In addition to this site, two unique
2167H. Ivanova et al. / Biochimica et Biophysica Acta 1843 (2014) 2164–2183for the ATP regulation of the Ca2+ release per se, which in this isoform
must occur by an alternative site [13].
2.1.5. Regulation by thiol modiﬁcation
Thiol-modifying agents like thimerosal, affect IP3R function in an
isoform-speciﬁc manner. Thimerosal at lowmicromolar concentrations
promotes IP3R-mediated Ca2+ signaling in a variety of cellular systems,
including oocytes [91], hepatocytes [92,93], HeLa cells [94] and A7r5
smooth-muscle cells [36]. Thimerosal displayed a bell-shaped activation
of IP3R1-mediated Ca2+ release, with concentrations of thimerosal
lower than 10 μM being stimulatory by sensitizing the channels to low
IP3 concentrations and increasing total Ca2+ ﬂux, while concentrations
higher than 10 μM being inhibitory [36,95]. These effects of thimerosal
were selective for IP3R1, since IP3R3-channel function was not promot-
ed by thimerosal [96]. The stimulatory action of thimerosal on IP3R1 but
not IP3R3 channels correlatedwith its ability to enhance [3H]IP3 binding
to the full-length IP3R1 or to the ligand-binding domain of IP3R1 but not
to IP3R3 [97,98]. Furthermore, the stimulation of IP3R1 by thimerosal
was clearly potentiated by the presence of free Ca2+ [25]. These func-
tional observations correlated well with an increase in the Ca2+-
dependent intramolecular binding of the ligand-binding core (a.a.
226–604) with the suppressor domain (a.a. 1–225) of IP3R1, while in-
teractions between theN- and C-terminus of IP3R1 remained unaffected
by thimerosal [25]. The ligand-binding core and the suppressor domain
of IP3R3 could not interact with each other, neither in the absence nor in
the presence of thimerosal. The effects of thimerosal on IP3R2 channels
remain controversial, as thimerosal did not enhance agonist-induced
Ca2+ release in RBL-2H3 cells, while it did in hepatocytes [97]. A recent
study compared the effect of thimerosal on all three IP3R isoforms
ectopically expressed in DT40-TKO cells [99]. This study indicated that
moderate concentrations of thimerosal sensitized IP3R1 and IP3R2, but
rather decreased the sensitivity of IP3R3 to IICR, while high concentra-
tions of thimerosal inhibited both IP3R1 and IP3R3, but not affected
IP3R2. Thimerosal also stimulated [3H]IP3 binding to the ligand-
binding domain (a.a. 1–604) of IP3R1 and IP3R2, but not to that of
IP3R3 [99]. The former required the presence of cysteine residues
both in the suppressor and in the binding-core domain. Although the
cysteine residues responsible for thimerosal-induced IP3R1 sensitiza-
tion remain elusive and further studies are needed, C214 in the suppres-
sor domain and C556 in the IP3-binding core have been proposed
as potential candidate target sites for thimerosal [99]. These studies un-
derpin the concept that thiol-modifying agents, like reactive oxygen
species (ROS),may have differential effects on IP3R isoforms. Hence, dif-
ferential IP3R-isoform expressionmay determine the cellular sensitivity
towards oxidative stress. For instance, the expression of the IP3R3
isoform in bronchial epithelial cells might be part of a mechanism that
allows this tissue to cope with its exposure to constitutive oxidative
stress [96], thereby avoiding cell death and tissue malfunction. The
role of ROS in the IP3R regulation will be discussed in more detail in
Section 5.
2.1.6. Regulation by phosphorylation
IP3Rs are targets for numerous protein kinases including PKA,
protein kinase B (PKB/Akt), protein kinase C, cGMP-dependent protein
kinase, Ca2+- and CaM-dependent protein kinase II, cyclin-dependent
kinases (CDK), mitogen-activated protein kinases (MAP kinases),
polo-like kinases (PLK), Rho kinases, mammalian target of rapamycin
(mTOR) and various protein tyrosine kinases (for reviews see [2,100]).
We will focus in this review on those kinases for which a clear
isoform-speciﬁc regulation has been demonstrated.
IP3R1 is stoichiometrically phosphorylated by PKA at S1588 and
S1755 (Fig. 1), which are canonical PKA-substrate motifs [101]. The pe-
ripheral splice isoform S2− was preferentially phosphorylated at the
former site, while the neuronal isoform S2+ was phosphorylated at
both sites, butmainly at the latter [101]. Contradictory functional effects
were reported in earlier studies, probably reﬂecting the simultaneouspresence of other IP3R isoforms [102], the phosphorylation of other
proteins involved in Ca2+ handling or indirect regulation of PKA itself
[100]. In DT40-TKO cells it was found, using alanine-substituted and
phosphomimetic mutants, that phosphorylation of S1755 was neces-
sary and sufﬁcient for a marked activatory effect in the S2+-splice vari-
ant, while both sites contributed to activation of the S2− isoform [103,
104]. Single-channel analysis in lipid bilayers and whole-cell patch
clamp of IP3R channels expressed in the plasma membrane [90]
revealed that the primary effect of a phosphomimetic activation was
an increase in the open probability at a subsaturating [IP3], reﬂecting
effects on the kinetics of the channel opening and closing [90].
The analysis of PKA phosphorylation of IP3R2 and IP3R3 was more
difﬁcult because consensus sites were absent in these isoforms [13].
Mutational analysis and controlled tryptic digestion revealed a unique
PKA phosphorylation site in IP3R2 at S937 (Fig. 1) [105]. PKA activation
resulted in enhanced Ca2+ signals and IP3R2 activity in DT40-TKO cells
expressing thewild-type but not the S937Amutated channel, indicating
that this site is a bona ﬁde PKA phosphorylation site [105]. Enhanced
activity of IP3R2 and IICR were also observed in AR4-2J cells, which are
pancreatic acinar cells expressing almost exclusively IP3R2 [106]. Muta-
tional analysis of PKA-phosphorylation sites in IP3R3 revealed three
sites (Fig. 1) [107]. No functional effect was however found upon phos-
phorylation of the most prominent site (S934) in DT40-TKO cells
expressing IP3R3. This means that although IP3R3 is a substrate for
PKA phosphorylation, it is not clear what could be the functional conse-
quences for this isoform [108]. Nevertheless, Guillemette and co-
workers showed that [3H]IP3 binding and IICR were increased in
RINm5F cells, which is a rat insulinoma cell line mainly expressing
IP3R3. They concluded that PKA-dependent phosphorylation of IP3R3
plays an important role in endocrine-cell responses to external stimuli
[109].
PKB/Akt is a proto-oncogene involved in several cellular survival
processes [110]. All three IP3R isoformshave the highly conserved phos-
phorylation motif RXRXX(S/T) in their C-terminus, and the phosphory-
lation at this site by PKB/Akt promoted survival (Fig. 1) [111,112]. The
modiﬁcation was enhanced by the Ca2+-induced conformational
change of the IP3R [113], which may be a feedback mechanism to
favor store reﬁlling after Ca2+ release. The anti-apoptotic effect of
phosphorylation by PKB/Akt has been linked to inhibition of ER Ca2+
release [112,114], as will be further discussed in Section 4.2.1.
Several kinases that affect the cell cycle and cell proliferation can
also regulate the IP3Rs in an isoform-dependent way. Their exact
physiological role is however still unclear, as various kinases can target
the same sites and as the phosphorylation sites involved have not all
been identiﬁed. Moreover, during cell-cycle progression several kinases
are simultaneously active, potentially leading to a more complex
regulation of the IP3R. CDK1/cyclin B phosphorylates IP3R1 at S421
and T799, but neither of the two sites is conserved in IP3R2 and only
the second one is conserved in IP3R3. CDK1/cyclin B-mediated
phosphorylation of IP3R1 resulted in an increased IP3-binding and IICR
activity [115,116].
The MAP kinases ERK1/2 can potentially recognize three sites
present in mouse IP3R1 (S436, T945 and S1765) though not in IP3R2
or IP3R3. The phosphorylation of S436, located in a critical region of
the IP3-binding core [117], leads to an increased interaction between
the suppressor domain and the IP3-binding core and to a decreased
IP3 binding and IICR in various cell types [118,119]. In contrast to somat-
ic tissues, ERK however appeared to stimulate IICR in oocytes, but this
may be due to an indirect effect, e.g. by enhancing IP3R1 phosphoryla-
tion by another kinase [120,121]. An interesting candidate for the latter
is PLK1, which has in IP3R1 four potential phosphorylation sites (T1048,
T1492, S1790 and T2656), two of them (T1492 and T2656) being
conserved in the other isoforms. In vitro phosphorylation experiments
supported a PLK1-mediated phosphorylation of T2656, and in addition
demonstrated a signiﬁcantly higher phosphorylation of IP3R3 compared
to IP3R1 [122].
Fig. 2. Triangle-diagram representation of the relative expression of the three IP3R iso-
forms at the mRNA level in various tissues, primary cells and established cell lines. Most
cell types express more than one or all three IP3R isoforms. In many cases there seems
to be a preference, e.g. IP3R1 in cerebellum and neurons, IP3R2 in liver, and IP3R3 in
many cultured cell types. The relative expression levels of the three isoforms were obtain-
ed by a RT-PCR method as described previously [128,129]. Data obtained from RT-PCR
were previously compared with determinations of the three IP3R isoforms at the protein
level using isoform-speciﬁc antibodies, and were found to be in good agreement [130].
The values on the diagram represent the percentage of each isoform in a particular cell
type and can be read on the respective axis.
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sites implicated in cell-cycle control was taken by Machaca and collab-
orators, who performed a comprehensive phospho-peptide mapping
of the endogenous IP3R1 during Xenopus laevis oocyte maturation
[123]. This study covered nearly 75% of the cytosolic part of Xenopus
IP3R1 and indicated a speciﬁc phosphorylation at T931, T1136 and
S1145. All three sites are compatible with a site targeted by a MAP ki-
nase or a CDK, but only the site encompassing T931 is highly conserved
between species and corresponds to the above-mentioned T945 in
mouse. Subsequent work expressing mutated IP3R1 in DT40 cells
suggested that, similarly to what was found for S436 in somatic cells,
its phosphorylation decreased both IP3 binding and IICR [124].
2.1.7. Regulation by other protein interactions
There is an increasing number of identiﬁed IP3R-interacting proteins
(N60). This number includes not only regulatory proteins but also scaf-
folding proteins, protein kinases and phosphatases, structural proteins
and motor proteins. An overview of all these interactions is beyond
the scope of this review and is documented in several excellent reviews
[2,14,15,125,126]. For many of these proteins the exact binding site is
not known, and information about different isoforms is lacking
(Table 1). Moreover, the sequence information is not sufﬁcient for
predicting isoform-speciﬁc interactions. Only in a few cases a clear
preference for a particular isoform has been documented [126].
2.2. Differential expression of IP3R isoforms
The three IP3R isoforms have distinct but overlapping expression
patterns, with most cell types expressing more than one subtype [2,
127]. A quantiﬁcation of the relative expression levels using RT-PCR
[128,129] or using a combination of speciﬁc and common antibodies
[46,130–132], yielded values for different cell types and tissues. A
triangle-diagram representation of the relativemRNA-expression levels
of the three IP3R isoforms obtained via RT-PCR is presented in Fig. 2.
While most cell types express two or even all three isoforms, there is
often a predominant isoform, e.g. IP3R1 in neuronal cells, IP3R2 in liver
and muscle cells and IP3R3 in most cultured cell types. It is also striking
that primary cells (e.g. endothelial cells) switch to a higher proportion of
the IP3R3 isoform after a few passages in culture [133]. IP3R-expression
levels were indeed found to be modiﬁed during development and dif-
ferentiation [127]. Promoter regions have been identiﬁed for IP3R1
[134–137], IP3R2 [138] and IP3R3 [139], and it is evident that there are
signiﬁcant differences that could explain cell type- and differentiation-
dependent expression, but no general pattern is apparent. NumerousTable 1
Best documented proteins interacting with the various IP3R isoforms. Proteins have been divide
speciﬁc properties, and (c) those which are yet only documented for particular isoforms. The in
Proteins are in each group ordered alphabetically.
a. All three isoforms b. Exclusively one isoform
80 K-H protein kinase C substrate,
C-terminal tail [346]
CaM, binding site in the regu
of IP3R1 and IP3R2, but not o
and in S2−-splice form of IP3
Bcl-2 and Bcl-Xl, C-terminal tail and
modulatory domain [190,301,307,308]
ERp44, third luminal loop of
CaBP-family members and CIB, suppressor
domain [77,348–350]
GRP78/Bip, third luminal loo
CaM, suppressor domain [65,352]
GIT1 and GIT2, C-terminal tail [331]
IRBIT, IP3-binding site [356,357]
KRAS, ligand-binding domain [359]
Na+,K+-ATPase, ligand-binding domain [361]
RACK1, suppressor domain and
IP3-binding core [363]studies have shown a potential regulation of IP3R expression by factors
such as retinoic acid, TGF-β and phorbol esters (as reviewed in [127]).
Many studies have shown that IP3R1 plays a crucial role in brain func-
tion (as reviewed in [15]). Synaptic activity regulates the expression of
IP3R1 in neurons depending on transcription and protein synthesis
and requires PKA activity [140]. It was shown that TNFα regulates
IP3R-mediated Ca2+ responses in neurons via a JNK-dependent increase
in IP3R-protein levels [141]. A promoter region encompassing a speciﬁc-
ity protein-1 binding site was necessary for JNK-mediated regulation,
pointing to a key pathway for the TNFα-induced modulation of IP3R1
in neurons [142]. Ca2+ signal-transduction pathways are clearly in-
volved in the regulation of IP3R1 [143,144]. An example is the increasedd in those (a) demonstrated to interact with all three isoforms, (b) those showing isoform-
teraction site and/or isoform concerned are described and pertinent references are given.
c. Only documented for a particular isoforms
latory domain
f IP3R3 [63],
R1 [66]
Ataxins-1 and -2, C-terminal tail of IP3R1 [347]
IP3R1 [62] Beclin 1, ligand-binding domain of IP3R1 and
IP3R3 [320,324]
p of IP3R1 [61] Carbonic anhydrase related protein, modulatory
domain of IP3R1 [351]
Chromogranins A and B, between pore region
and transmembrane domain 6 of IP3R1 [353–355]
Cytochrome C, C-terminal tail of IP3R1 and IP3R3 [276]
DANGER, modulatory domain of IP3R1 and IP3R3 [358]
GAPDH, modulatory domain of IP3R1 [360]
Gβγ, IP3R1 [362]
HSP90, IP3R3 [364]
Huntingtin, C-terminal tail of IP3R1 [365]
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pertension and required activation of the calcineurin-nuclear factor of
activated T cells axis [145]. It was also found that dopamine receptors
regulate IP3R1 expression via activator protein 1 and nuclear factor of
activated T cells mediated transcription [146–148].
IP3R2 and IP3R3 double-KOmice showed severe impairment of sali-
vation. This indicates that IP3R2 and IP3R3 are the major Ca2+-release
channels involved in digestive enzyme secretion and possibly in secre-
tory processes of other exocrine tissues [149]. Moreover, analysis of
the double-KOmice also revealed a role for these isoforms in the differ-
entiation of granular cell precursors [150].
In line with the observation that IP3R3 was preferentially expressed
in cultured cells [129,133], a link between IP3R3 expression and cell pro-
liferation was also found in the estrogen-dependent MCF-7 breast-
cancer cell line [151]. Higher IP3R3 levels in these cells did not lead to in-
creased apoptosis as found in other studies [152]. The link between
IP3R3 and proliferation may be the speciﬁc temporal pattern character-
istic for Ca2+ signals evoked by IP3R3 [23,153] that may lead to more
efﬁcient transcription-factor activation [151]. Yet, in other cancer cell
models, IP3R3 expression seems to be repressed. A very recent study el-
egantly comparing a colorectal cancer cell line expressing K-RASG13D/wt
and its isogenic derivative cell line lacking K-RASG13D (K-RAS−/wt cells)
showed that IP3R3 expression was lower and IP3R1 expression was
higher in K-RASG13D/wt cells than in K-RAS−/wt cells [154]. This IP3R-
isoform remodeling in K-RASG13D/wt cells was accompanied by a lower
steady-state [Ca2+]ER and a reduced agonist-induced [Ca2+] rise in the
cytosol and the mitochondria, thereby resulting in a decreased apopto-
tic sensitivity to stimuli that act through Ca2+ signaling, likemenadione.
As discussed in Pierro et al. [154], these observations correlate well with
a micro-array analysis of a variety of isogenic K-RAS-deﬁcient cell lines,
showing an increase in IP3R3 mRNA-expression levels. Furthermore,
also earlier reports have linked alterations in K-RAS expression to
changes in IP3R-isoform expression. For instance, ITPR2, the gene
encoding for IP3R2, seems to be co-ampliﬁed with KRAS2 ampliﬁcation
in non-small cell lung carcinoma [155].
The expression of IP3R isoforms can also be regulated at a post-
transcriptional level by speciﬁc degradation, which occurs for the
three isoforms with different kinetics [130]. Moreover, it was recently
reported that the translation of the IP3R2 messenger was regulated by
the muscle-speciﬁc miRNA-133a [156]. The mutual antagonism
between IP3R2 and miRNA-133a was found to regulate Ca2+ signals
and cardiac hypertrophy. Thereby, hypertrophic stimuli that engaged
IICR lead to a decrease inmiRNA-133a levels and subsequently a further
augmentation of IP3R2 levels and therefore pro-hypertrophic Ca2+
release [156]. This mechanism is speciﬁc for IP3R2 in the heart, but
it is conceivable that similar mechanisms involving miRNAs may be
operative for IP3R1 and IP3R3 as well.
IP3Rs are most abundantly expressed in the ER but they are also
found in the nuclear envelope, Golgi apparatus, secretory vesicles and
plasma membrane (as reviewed in [127]). Even within the ER there is
no uniform distribution of IP3Rs [157,158]. The compartmentalization
and formation ofmicrodomains of Ca2+ signaling have been recognized
as very important for speciﬁc cell functions as e.g. in pancreatic acinar
cells [159,160]. Of particular relevance for the present review is the
close apposition between the ER and mitochondrial membranes (the
mitochondria-associated ER membranes, MAMs) with a key role for
IP3Rs to mediate speciﬁc ER-to-mitochondria Ca2+ transfer [161,162].
The IP3R contributes at the MAMs to the physical link between the ER
and themitochondria as the cytosolic chaperone glucose-regulated pro-
tein 75 was found to tether the N-terminal domain of IP3R1 to the
mitochondria-located voltage-dependent anion channel 1 [163]. IP3R3
was found in CHO cells to co-localize more closely with the mitochon-
dria and to preferentially transmit Ca2+ signals to these organelles
[152,164]. The importance of these microdomains for cell fate and the
role of particular IP3R isoforms will be further discussed in Sections 3
and 4.3. ER Ca2+ content in cell-fate regulation
The ER Ca2+ content is very important for cell-fate decisions. A high
[Ca2+]ER makes the cell prone to apoptosis as higher amounts of Ca2+
can be released by the IP3R after cell stimulation. As the IP3R is a part
of the protein complex in theMAMs, the increased IP3R activity can eas-
ily lead tomitochondrial Ca2+ overload (for review, see [165]). The sub-
sequent mitochondrial outer-membrane permeabilization, generally
considered as a point-of-no-return to cell death, will lead to the release
of pro-apoptotic factors like e.g. cytochrome C [166]. A low [Ca2+]ER is
therefore protective against apoptosis, but too low levels lead to the ac-
cumulation of misfolded proteins in the ER, resulting in ER stress, and
the cells develop the so-called unfolded protein response (UPR) [167,
168]. Classical mediators of the UPR are the ER-stress sensors inositol-
requiring enzyme 1α (IRE1α), protein kinase RNA-like ER kinase
(PERK), and activating transcription factor 6 (ATF6) [169]. The UPR
can lead to autophagy, as part of the pathway to restore cell homeosta-
sis, or to apoptosis if the homeostasis cannot be recovered [170–173].
Independently of the UPR, if for any reason Ca2+ transfer from the ER
to the mitochondria drops below a threshold value, energy production
by themitochondria is not guaranteed anymore and autophagy also fol-
lows [174]. Finally, high levels of Ca2+ release into the cytosol generally
will be associatedwithmitochondrial Ca2+ overload and the opening of
the mitochondrial permeability transition pore [175,176], leading to a
variety of cell-death modalities, including apoptosis and necrosis
[177]. The contribution of the mitochondrial Ca2+ uniporter (MCU) in
this concept remains to be studied further, since cardiomyocytes obtain-
ed fromMCU−/−mice displayed reducedmitochondrial Ca2+ uptake in
comparison to their wild-type counterparts andwere resistant to Ca2+-
dependent opening of the mitochondrial permeability transition pore
[178]. Surprisingly, mouse embryonic ﬁbroblasts (MEF) obtained from
MCU−/− mice were not protected against a variety of cell-death in-
ducers that (partially) act through Ca2+ signaling. These cellular obser-
vations were supported by in vivo data showing that injury resulting
from ischemic reperfusion protocols was not different in wild-type
versusMCU−/−mice [178].
In the balance between maintaining an appropriate [Ca2+]ER and
appropriate Ca2+ signaling, the various IP3R isoforms and a number of
proteins interacting functionally and/or structurally with them, play a
crucial role, as will be discussed below.
3.1. Control of the [Ca2+]ER
The [Ca2+]ER is primarily related to the [Ca2+]cyt, which itself results
from the balance between the various pathways for Ca2+ inﬂux and
Ca2+ efﬂux in and out of the cell [179]. Moreover, it is important to
indicate that depletion of the ER Ca2+ stores induces the opening
of plasmalemmal store-operated Ca2+-entry channels, aiming to re-
establish ER Ca2+ homeostasis [180,181].
Ca2+ uptake in the ER is driven by sarco- and endoplasmic-
reticulum Ca2+-ATPases (SERCA). The housekeeping SERCA2b is the
most widely expressed isoform, and ER loading in most cell types
generally depends on this ion pump [182,183]. Except for the Ca2+-
release channels like IP3Rs and RyRs, the ER membrane displays an
inherent Ca2+ leak. It is not yet clear which protein or proteins are re-
sponsible for this Ca2+ leak, and many candidates have been proposed,
including B-cell lymphoma-2 (Bcl-2), B-cell lymphoma-extra-large
(Bcl-Xl), members of the transmembrane Bax inhibitor motif-
containing (TMBIM) family proteins, calcium homeostasis modulator 1,
presenilins, ER-localized channels of the transient receptor potential-
channel family, pannexins, the translocon complex, and truncated
forms of IP3Rs and SERCA pumps [184–186]. For most of these candidate
proteins evidence for a general role is lacking. Recently a screen of 250
siRNAs on Ca2+ signaling presented evidence for a role of three proteins
in the Ca2+ leak, i.e. IP3R1, Orai2, and presenilin 2 [183]. It is interesting
to note that a number of plasmalemmal Ca2+-permeable channels, like
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uting to the ER Ca2+ leak. The mechanisms are not fully understood, but
it has been proposed that these channels could temporarily reside and
function as a Ca2+-leak channel “en route” from the ER to the plasma
membrane [183]. We will focus here on the most documented Ca2+-
leak mechanisms proposed to be involved in cell-fate regulation.
3.1.1. IP3Rs
Although the IP3R does not display a signiﬁcant activity in the
absence of cytosolic IP3 [2], the IP3 concentration present under non-
stimulated conditions can be sufﬁcient to allow this channel to set up
the leakage of Ca2+ out of the ER [188]. Moreover, the IP3R can be
sensitized to basal IP3 levels by regulatory mechanisms including phos-
phorylation [189] and interaction with other proteins [190,191] leading
to (partial) depletion of the ER. Finally during apoptosis the active cas-
pase 3 can cleave the IP3R1 (but probably not the other isoforms) just
downstream of the 1888DEVD consensus site [192]. The remaining
membrane-inserted C-terminal part of the IP3R is responsible for an
IP3-independent Ca2+ release out of the ER [193,194]. The role of this
cleavage in apoptosis is still a matter of debate as will be further
discussed below (Section 4.1.1) [195,196]. Recently, IP3R1 also emerged
as a substrate of calpains, resulting in the accumulation of a stable
proteolytic fragment of ~95 kDa [197]. Amino acid sequencing of the
N-terminus of this fragment elucidated a speciﬁc calpain-cleavage site
between residues 1917 and 1918 of the rat IP3R1 conserved among
mouse and human IP3R1, which does not seem to be present in IP3R2
or IP3R3 channels. Strikingly, this calpain-cleavage site is located in the
close proximity of the caspase 3-cleavage site (Fig. 3). Recombinant
expression of the calpain-cleavage product of IP3R1 seemed toxic to
cells, likely due to an increased ER Ca2+ leak from these cells, resulting
in a signiﬁcant but partial depletion of the ER Ca2+ stores. At the
biophysical level, this phenomenon could be explained by a single-
channel analysis, which demonstrated that this C-terminal IP3R1
fragment forms channels with a similar conductance as wild-type
IP3R1 and with a bell-shaped dependence on the [Ca2+]cyt, but that
were not gated by IP3 and displayed a signiﬁcantly higher open proba-
bility at resting [Ca2+]cyt [197].
3.1.2. Bcl-2-family members
Bcl-2 itself as well as the related Bcl-Xl are prototypical anti-
apoptotic proteins inhibiting apoptosis primarily by interacting with
the pro-apoptotic family members [198]. In addition, other functions
have been described [199,200]. In particular, these proteins have the
ability to form ion pores in synthetic membranes [201,202]. Subse-
quently, it was shown that they decreased the ER Ca2+ content and
were proposed to form a Ca2+-leak in the ER [203,204]. However, over-
expression of Bcl-2 did not lead to a decreased ER Ca2+ content in all
studies (as reviewed in [205]). Furthermore, a study in DT40-TKO cells
engineered to express a single IP3R isoform indicated a reduction of
the [Ca2+]ER by Bcl-Xl only in the cells expressing IP3R3 but not in
those expressing either IP3R1 or IP3R2 [206].
In any case, the action of Bcl-2 and Bcl-Xl on the [Ca2+]ER is more
complex than only providing a Ca2+-leak pathway, since these two
proteins affect different Ca2+-handling proteins. First, Bcl-2 can directly
or indirectly interact with SERCA pumps [207]. More recent data indi-
cated that Bcl-2 is capable to inactivate SERCA [208]. This inactivation
can be counteracted by heat-shock proteins like HSP70 [209]. Second,
both Bcl-2 and Bcl-Xl can also directly interact with the IP3R as will be
discussed in detail below (Section 4.2.2). Bcl-2 proteins have been im-
plicated in the regulation of the PKA-dependent phosphorylation state
of IP3R1 channels [189]. With the rise in the ratio of anti-apoptotic
over pro-apoptotic Bcl-2 proteinsmore binding of Bcl-2 to IP3Rswas ob-
served,which resulted in an enhanced PKA-dependent phosphorylation
of IP3R1. This led to a hypersensitization of IP3Rs to basal IP3 levels,
thereby increasing the basal Ca2+ leak through these hypersensitive
IP3Rs and decreasing the steady-state [Ca2+]ER. Third, recent data fromvarious groups indicate that the interaction of Bcl-2-family proteins
with the IP3R may even be more complex, [210], with effects on IP3R
phosphorylation [211] that can be mediated through its interaction
with DARPP-32 and the phosphatases calcineurin and protein phospha-
tase 1 [212] on the IP3-binding site ([213] and data not shown), and on
IP3R degradation [214]. Finally, Bcl-2-family members may act on other
ER Ca2+-leak mechanisms, like Bax Inhibitor-1 (BI-1), a member of the
TMBIM family [215]. These results indicate that Bcl-2 and related pro-
teins can affect ER Ca2+-store loading through different mechanisms
and that the eventual effect, increased or decreased Ca2+ loading and
increased or decreased Ca2+ release, will be strongly dependent on
the cellular context.
3.1.3. TMBIM-family proteins
TMBIM proteins are a family of conserved ancestral cell-death
protectors and their deregulation was implicated in various types of
cancer [216–219]. The founding member of this family, a small
(26 kDa) protein, called BI-1 (TMBIM6), was identiﬁed in a high-copy
Bax-suppressor screen in yeast [216]. Recently, BI-1 has been settled
to be a 6-transmembrane domain protein, which strongly resembles
the hydrophobicity proﬁle of the other TMBIM-family members [219].
Consistent with its ER localization, BI-1 was shown to protect against
ER stress-induced cell death in mammalian cells [220]. BI-1 was pro-
posed to have a role in decreasing the [Ca2+]ER downstream of Bcl-Xl
[215]. This Ca2+-leak function of BI-1 can be explained by severalmech-
anisms. BI-1 could act as a pH-sensitive Ca2+-leak channel in the ER,
whereby the C-terminal part of the protein dipping into the membrane
would be crucial [221–223]. Alternatively, a Ca2+/H+-antiporter mech-
anism has been proposed [224].
In addition, BI-1 also binds and sensitizes IP3Rs through an interac-
tion between the C-terminal channel domains of both proteins. Ca2+
ﬂux through BI-1 is not required for BI-1-mediated sensitization of
IP3Rs, since a Ca2+-channel-pore-dead mutant of BI-1 remains capable
of sensitizing IP3Rs [191]. Although binding of BI-1 has only been dem-
onstrated for IP3R1, it is likely that also other isoforms are targeted by
BI-1, since IP3R sensitization by BI-1 was observed in MEF cells, which
express high levels of IP3R3. It has been reported that BI-1 increases
basal autophagy via promoting Ca2+ ﬂux through IP3Rs, thereby
decreasing the amount of Ca2+ available for transfer from the ER to
the mitochondria, subsequently resulting in activation of AMPK and
triggering autophagic ﬂux [174,225–227]. These ﬁndings seem to be in
contrast with another report demonstrating that BI-1-knock-out cells
displayed increased autophagic ﬂux [228]. Yet, this could implicate
that BI-1 could function as a rheostat controlling basal autophagic ﬂux.
Using in vitro (cell lines) and in vivo (Drosophila melanogaster and
zebraﬁsh) models of ER stress-induced apoptosis, it was shown that
during ER stress glutamate receptor, ionotropic NMDA-associated pro-
tein 1 (GRINA/TMBIM3), another BI-1-family member, is upregulated
in a PERK-dependent manner. GRINA also interacts with IP3R1 and
IP3R3, forming a complex and cooperating with BI-1 during ER stress
(Fig. 3). GRINA suppresses the depletion of the ER Ca2+ stores and
thereby prevents ER stress-induced apoptosis [229]. This revealed a
critical and dynamic role for GRINA in suppressing ER stress by acting
as an IP3R inhibitor [229]. BI-1 may prevent IP3R inhibition by GRINA
by forming a complex in healthy, non-stressed cells and may further
support viability by sensitizing IP3R function, subtly lowering the
[Ca2+]ER and increasing basal autophagy.
Golgi anti-apoptotic protein (GAAP/TMBIM4) is another TMBIM-
family member that has been proposed to bind and regulate IP3Rs
(Fig. 3). The topology of this protein that is conserved among all
eukaryotes and is present even in some poxviruses, showed a 6-
transmembrane domain proﬁle, which could serve as a model for
other TMBIM-family members [220]. Its anti-apoptotic properties
have been linked to altered intracellular Ca2+ dynamics at the level of
the plasmamembrane and at the level of the ER. Human GAAP overex-
pression in U2OS cells,whichmainly express IP3R3, suppressed agonist-
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to IP3 [230]. At themolecular level, hGAAP co-immunoprecipitatedwith
IP3R3, indicating that endogenous IP3R3/hGAAP–protein complexes are
present in a cellular context.3.1.4. Translocon
The translocon or SEC61 complex is a speciﬁc protein complex
forming a channel through the ER membrane needed for the transloca-
tion of polypeptides during protein translation. In its completely open
state, e.g. after puromycin treatment, it can also allow the transfer of
Ca2+ out of the ER [231,232]. However, as can be expected formaintain-
ing cell survival, the closed state predominates [233] suggesting
the presence of regulatory mechanisms. Ca2+ transfer through the
translocon appears to be inhibited by CaM [234] as well as by the
glucose-regulated protein 78/immunoglobulin heavy chain-binding
protein (GRP78/BiP) [235,236]. During ER stress, the binding of the
luminal ER protein GRP78/BiP to unfolded or misfolded proteins
releases the translocon from this inhibition. The increased Ca2+ leak
from the ER will thereby contribute to the further development of the
UPR [237] and/or to the eventual demise of the cell [236].
3.1.5. Presenilins
Presenilins 1 and 2 are intramembrane-cleaving proteases contain-
ing 9 transmembrane domains and having a cytosolic N-terminus and
a very short C-terminus [238]. Both of them can form the catalytical
unit of the γ-secretase complex which is responsible for the generation
of the amyloid-β peptides related to Alzheimer's disease [238–240].
Presenilins can be expressed at the ER and according to some recent
studies especially at the MAMs, where they can modulate the connec-
tion between the ER and the mitochondria [241–243]. Interestingly,
multiple, non-exclusive, roles for presenilins in ER Ca2+ handling have
been described. Presenilins were proposed to directly form a Ca2+-
leak channel [244,245]. Despite the controversy [246], a recent unbiased
siRNA screen conﬁrmed that at least presenilin 2 acts as a Ca2+-leak
channel [183].
Presenilins can however also affect Ca2+ handling by other mecha-
nisms.Mutated formsof presenilins can stimulate theactivity [247–252]
ormodulate the expression levels of the IP3R [253] or theRyR [254–258]
as well as regulate SERCA pumps [259]. Presenilins may also affect
store-operated Ca2+ entry in the cell, which may be related to the
[Ca2+]ER [240], or modulate lysosomal Ca2+ homeostasis [260].
3.2. Regulation of IP3R isoforms by luminal ER proteins
With respect to cell fate, the regulation of the IP3Rs by a number of
luminal ER proteins appears important [167]. These regulatory mecha-
nisms display IP3R-isoform speciﬁcity.Fig. 3. Differential regulation of the IP3R isoforms by various pro- and anti-apoptotic
proteins. The three isoforms of the IP3R, located at the ER membrane, are shown with
their cytosolic N- and C-termini and the six transmembrane domains (panels A, B and C).
The binding sites for the various cell-fate regulators are indicated. The anti- and the pro-
apoptotic proteins are presented in green and in red, respectively. The three isoforms are
targeted by Bcl-2-family anti-apoptoticmembers, since Bcl-2 and Bcl-Xl bind to themodula-
tory domain, regulating receptor activity, and together with Mcl-1 to the C-terminus of the
IP3Rs. GIT1 and GIT2 have two different binding sites in the C-terminal domain of type-1,
-2, and -3 receptors and their binding leads to suppression of IICR. All the isoforms are
phosphorylated and inhibited by PKB/Akt and targeted sites are indicated.Many interactions
were observed only for a speciﬁc isoform. (A) Beclin 1 is recruited to theN-terminus of IP3R1,
leading to a suppression of autophagy. IP3R1 is a target of calpain and caspase 3, but binding
of Bok could prevent caspase 3-dependent cleavage. GRINA is another BI-1-family member,
besides BI-1 itself, that binds to IP3R1. Cytochrome-C interactionwith the C-terminus causes
pro-apoptotic Ca2+ release. In normal physiological conditions BiP binding to the luminal
loop of IP3R1 promotes basal Ca2+ release and inhibits sigma 1-receptor function. Upon ER
stress, ERp44 is upregulated and disrupts BiP complexes with IP3R1 and with the sigma-1
receptor, causing inhibition of IP3R1 by ERp44. During oxidative stress, ERO1α disrupts the
interaction of IP3R1 with ERp44, which leads to increased pro-apoptotic Ca2+ release.
(B) IP3R2 was also proposed to be cleaved by caspase 3, but the exact cleavage site
needs to be further determined. Bok binds to the same site in IP3R2 as in IP3R1. From the
BI-1-family members BI-1 and GAAP have been shown to regulate this isoform. (C) Beclin
1 also targets the N-terminus of IP3R3. This isoform was proposed to be cleaved by calpain,
but the exact cleavage site is not known. The site phosphorylated by PKB/Akt is indicated,
as well as the inhibitory action of PP2A and PTEN on PKB/Akt function. Cytochrome C also
binds to the C-terminus of this isoform. Under ER-stress conditions the released sigma-1
receptor from IP3R1 binds to and stabilizes IP3R3 on the MAMs. The latter leads to
pro-survival Ca2+ signaling via IP3R3.
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Under normal, unstressed conditions GRP78/BiP binds speciﬁcally to
IP3R1 by interacting with the variable part (residues 2463–2528) of its
luminal loop, located between transmembrane domains 5 and 6
(Fig. 3) [61]. GRP78/BiP stabilizes the IP3R1 and thus allows a higher
level of IICR. During ER stress, GRP78/BiP dissociates from the IP3R1 to
bind to unfolded or misfolded proteins leading to a decreased Ca2+ re-
lease through the IP3R1, which protects the ER from further depletion.
Therefore the IP3R1 can be considered as a fourth ER-stress sensor, in
addition to the classical ER-stress sensors IRE1α, PERK, and ATF6
[185]. GRP78/BiP also interacts with the sigma-1 receptor, thereby
inhibiting its function. During ER stress, the sigma-1 receptor is released
from GRP78/BiP, and acts to stabilize IP3R3 at the MAMs (Fig. 3) [261].
This in turn promotes Ca2+ transfer to the mitochondria and favors
cell survival.
3.2.2. Endoplasmic-reticulum resident protein 44 (ERp44)
ERp44 is a protein of the thioredoxin family which also speciﬁcally
binds to IP3R1, targeting the same variable part of the luminal loop as
GRP78/BiP (Fig. 3) [62]. Both proteins thus compete for the same region,
but in contrast to GRP78/BiP, ERp44 inhibits the IP3R1. During ER stress,
GRP78/BiP dissociates from IP3R1, while binding of the upregulated
ERp44 is increased, leading to a further inhibition of the IP3R1 and a
protection of the ER against further Ca2+ depletion [262].
The binding between ERp44 and IP3R1 is dependent on the [Ca2+]ER,
pH and redox state. An increased interaction between ERp44 and IP3R1,
and thus a decreased Ca2+ release, will occur under conditions of low
ER Ca2+ content, a reducing ER luminal environment, and an acidic lu-
minal pH [62]. Mutational analysis of ERp44 indicated that it interacts
with IP3R1 through a.a. 236–285, while on the IP3R1, the cysteine
residues 2496 and 2504 in the third luminal loop are required [62].
3.2.3. ER oxidase 1α (ERO1α)
ERO1α is a major catalyst of oxidative folding that can interact with
ERp44 [262]. During ER stress, ERO1α is upregulated, leading simulta-
neously to the retention of ERp44 as well as to ER hyperoxidation. Con-
sequently the interaction between ERp44 and IP3Rs is disrupted (Fig. 3),
resulting in an IP3R sensitization, enhanced Ca2+ release and apoptosis
[263]. Mitochondrial Ca2+ uptake is affected either directly, via H2O2
that is produced, or indirectly, e.g. via changes in Ca2+ handling by the
ER [264].
4. Cell-fate regulation from the cytoplasm
4.1. Pro-apoptotic proteins
4.1.1. Caspase 3
The requirement of IP3Rs for the execution of apoptosis has been
observed in many experimental and cellular paradigms [194,265,266],
but the mechanisms remain poorly understood. During the last decade,
evidence emerged for a positive feedback loop between IP3Rs and cas-
pase 3, the executioner caspase in apoptosis [194]. An extensive study
on the degradation of the three isoforms upon TNFα treatment associat-
ed the subsequent apoptosis with caspase-dependent degradation of
IP3R1 and IP3R2, but not of IP3R3 channels [267]. A consensus sequence,
DEVD, for caspase-3 cleavage was identiﬁed in the primary sequence of
the IP3R1 of mouse, rat and human origin [192] (see Section 3.1.1). Con-
sistentwith these in silicoﬁndings, both intrinsic and extrinsic apoptosis
inducers led in Jurkat cells to the cleavage of IP3R1 (Fig. 3), but not of
IP3R2 or IP3R3, as an early event. This proteolytic cleavage resulted in
the generation of a relatively stable C-terminal IP3R fragment of about
~90 kDa (IP3R1Δ1−1889), consistent with the position of the DEVD se-
quence in the full-length IP3R1 sequence (e.g. 1889DEVD in mouse,
1888DEVD in rat and 1835DEVD in human protein). The fragment is
localized in the ER membrane and contains all six transmembrane
domains and the Ca2+ channel-pore domain of IP3R1 [194,268]. Thisspeciﬁc caspase 3-mediated IP3R1 cleavage clearly preceded the general
decline of all IP3R isoforms in the later stages of apoptosis induction.
Consistent with the decrease in IP3R1 levels, recombinant caspase 3
attenuated IICR from mouse cerebellar microsomes. Mutant IP3R1
channels resistant to caspase-3 cleavage due to a D1889I change
(IP3R1Δcasp3) expressed in DT40-TKO cells were used to gain more
mechanistic insights [194]. Strikingly, while IP3R1-expressing cells
displayed increased sensitivity towards apoptosis inducers, IP3R1Δcasp3-
expressing cells were equally resistant to these cell-death treatments as
mock DT40-TKO cells. Both caspase-3 activation and apoptosis did not
strictly require IICR, since DT40-TKO cells expressing an N-terminally
deleted IP3R1 (IP3R1Δ1−225) unable tomediate IICR,were equally suscep-
tible to apoptotic stimuli and were equally potent in activating caspase 3.
While IICR was dispensable for apoptosis execution, caspase-3 activation
and apoptosis execution clearly required Ca2+ release via a mechanism
involving the production or the presence of IP3R1Δ1−1889 [194]. These
observations are consistent with ﬁndings in IP3R-deﬁcient T cells, which
are also impaired in caspase-3 activation [269]. An apoptotic stimulus ap-
peared to be required in IP3R1Δ1−1889-expressing cells to trigger cell
death and ER Ca2+-store depletion [195]. The C-terminal IP3R1 fragment
slightly enhanced the Ca2+ leak from the ER [195], supporting the con-
cept that the large regulatory domain of the IP3R1 is necessary to keep
the C-terminal channel domain in a closed state [193]. The extent of ER
Ca2+-store depletion differed from no effect or only a minor effect [195,
270] to a strong effect on the [Ca2+]ER [193]. Moreover, the C-terminal
channel fragment may also interact with plasmalemmal components
that mediate Ca2+ inﬂux from the extracellular environment.
Indeed, the Ca2+-channel-pore-dead IP3R1D2550A mutant, but
not IP3R1 lacking its cytosolic C-terminal tail, remained capable of
mediating a staurosporine-induced [Ca2+]cyt rise and promoting
caspase-3 activation in DT40-TKO cells [271]. Furthermore, caspase
3-mediated IP3R1 cleavage also occurred in physiological conditions
like ageing, since aged mouse oocytes displayed endogenous IP3R1
truncation, which was associated with disturbed IP3-triggered Ca2+
oscillations [195].
Recently, the relevance of IP3R1 truncation by caspase 3 for the exe-
cution of apoptosis has been questioned. It was reported that although
the proteolytic cleavage of IP3R1 by caspase 3 described in lymphoid
cells was also shown in neuronal cells [272], it did not occur in a variety
of other cell models, including HEK293 and HeLa cells [273]. Moreover,
IP3R1 was shown to be a poor substrate of caspase 3 in in vitro proteol-
ysis experiments and its cleavage was observed after the cleavage of
poly(ADP-ribose) polymerase (PARP), a hallmark of apoptosis [196].
Finally, the staurosporine-induced [Ca2+]cyt rise during the initiation
of apoptosis was independent of the presence or activation of caspase 3
[273]. In contrast, apoptosis seemed to depend on the induction of IP3
signaling, since an IP3 sponge was able to attenuate the staurosporine-
induced [Ca2+]cyt rise and cell death. Hence, these reports seem to advo-
cate that caspase 3-mediated IP3R1 truncation may not be a proximal
event and/or a driving mechanism in apoptosis execution but rather a
distal event resulting from on-going apoptosis [273].
Finally, a recent study by Yule and co-workers showed that during
apoptosis multiple proteolytic cleavage events occur, generating N-
and C-terminal IP3R fragments, but that these remain associated at the
ER membranes into tetrameric IP3R channels [270]. This was also
found for IP3R2 channels, for which recombinantly generated N- and
C-termini that do not occur in apoptotic cells could constitute channel
activity.
4.1.2. Calpain
Calpains are a class of cysteine proteases, directly activated by intra-
cellular Ca2+. Highly selective calpain-mediated degradation of IP3R
was observed [274] and originally, it has been proposed that in TNFα-
induced apoptosis in T-cell lymphoma cells, the activation of calpains
leads to the degradation of IP3R3 channels, while IP3R1 and IP3R2
channels were degraded by caspases [267]. Later, as described above
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(Fig. 3), resulting in the accumulation of a stable proteolytic fragment
of ~95 kDa, which was toxic to cells when recombinantly expressed
[197]. Neumar and co-workers generated an antibody that speciﬁcally
recognizes the calpain-cleaved IP3R1 fragment but not the full-length
IP3R1 protein (Ab2054) [197]. Using this antibody, it was shown that
cardiac arrest leads to the activation of calpains and subsequent cleav-
age of IP3R1 in vivo in the Purkinje cells of the cerebellum, which were
associated with increased neurodegeneration of the Purkinje cells.
Overexpression of the calpain-cleaved IP3R1 product in primary cortical
neurons resulted in a reduced neuronal viability in a limited subset of
neurons [275]. This was associated with impaired ER Ca2+-buffering
properties of these cells, resulting in increased glutamate-induced
[Ca2+]cyt rises and increased susceptibility to glutamate-induced
excitotoxicity of these neurons. Again, these observations seem in line
with results obtained for the caspase 3-cleaved IP3R1 fragment,
showing that expression of this C-terminal channel fragment is not
sufﬁcient to cause cell death, but rather may act as a co-incidence de-
tector in cells exposed to cell-death stimuli or cytotoxic conditions.
Furthermore, also during calpain-mediated cleavage of IP3R1, N-
and C-terminal fragments may remain associated to form functional
IP3R channels [270].
4.1.3. Cytochrome C
Cytochrome C is released from themitochondria uponmitochondri-
al outer-membrane permeabilization and is a critical factor for apopto-
sis induction. Boehning and co-workers found that cytochrome C
translocates to the ER upon apoptosis induction, where it binds to
IP3R1 and IP3R3 (Fig. 3) [276]. The expression of IP3R2 in the cell models
used (PC12 cells and HeLa cells) was too low to draw any conclusions
about possible binding of cytochrome C to this isoform. This ER translo-
cation of cytochrome C was independent of downstream caspase-3 ac-
tivation but required the presence of the IP3R, since DT40-TKO cells
failed to recruit cytochrome C to the ER membranes. Cytochrome C
binding to IP3R1 abolished the bell-shaped dependent regulation of
the channel by the [Ca2+]cyt, thereby preventing the inhibition of
IP3R1 channels by a [Ca2+]cyt higher than 1 μM. In intact cells exposed
to staurosporine, the translocation of cytochrome C to the IP3R was
associated with a sustained increase in [Ca2+]cyt. Furthermore, in
staurosporine-treated cells, the release of cytochrome C from the mito-
chondria seemed to be triggered by cytosolic Ca2+ spikes, which could
be prevented by the Ca2+ chelator BAPTA-AM. Exogenous expression of
the C-terminal tail of IP3R1, which contains the cytochrome C-binding
site, suppressed the increase in Ca2+ spiking and sustained elevation
of [Ca2+]cyt in response to staurosporine without interfering with
cytochrome C's ability to activate caspase 3. Thus, this study shows an
intimate link between mitochondrial cytochrome-C release and ER
Ca2+ release as a feed-forward mechanism for apoptosis induction
[277].
Further molecular studies revealed a 16-a.a. sequence (2621DNK
TVTFEEHIKEEHN2636) in the C-terminal tail of IP3R1 as the cyto-
chrome C-binding site (IP3RCYT) [278]. The four glutamate residues
seemed important for cytochrome-C binding, but yet the third gluta-
mate residue (E2633) is not conserved among IP3R2 or IP3R3,
although cytochrome C also has been suggested to bind to IP3R3. A
cell-permeable version of this peptide inhibited caspase-3 activity
and subsequent cell death upon the induction of either intrinsic or
extrinsic apoptosis pathways. The feedback of cytochrome C on
IP3Rs through binding to this C-terminal site has been conﬁrmed in
independent studies [279,280] in which electroporation of cyto-
chrome C in C6 glioma cells triggered apoptotic cell death that
could be partially counteracted by co-electroporating the IP3RCYT
peptide.
Finally, detailed kinetic studies revealed that the extrinsic Fas-
induced apoptosis required a biphasic Ca2+ release from the ER
[281]. The rapid release of Ca2+ was caused by the activation ofIP3Rs by IP3 produced from phospholipase Cγ (PLCγ), whereas
the slower, sustained release of Ca2+ was due to the release of
cytochrome C from the mitochondria and binding of cytochrome C
to the IP3R. Both processes were required to effectively induce
Fas-mediated apoptosis.4.1.4. Bok
Bok is a ubiquitously expressed multi-domain pro-apoptotic Bcl-2-
family member that resembles Bak and Bax. Consequently, cellular
overexpression of Bok results in apoptosis [282] in a Bak/Bax-
dependent manner [283]. Despite the fact that Bok is widely expressed,
particularly in B-lymphoid cells, while many other human cancers are
Bok deﬁcient, BOK−/−mice did neither display an increased lymphoma
development upon c-myc overexpression under the control of immu-
noglobulin heavy chain enhancer, nor any other major phenotypic
issue [284]. On the other hand, Bok overexpression resulted in a frag-
mentation of the ER, the Golgi apparatus and Golgi-derived compart-
ments, consistent with its presence not only at the mitochondria but
also at these intracellular compartments [283]. The targeting of Bok to
these ER/Golgi compartments occurs via its C-terminal transmembrane
domain, which is both necessary and sufﬁcient. Interestingly, cells lack-
ing Bok were slightly more sensitive to Golgi-fragmentation inducers
like brefeldin A and/or ER-stress inducers like tunicamycin, but not to
apoptosis inducers like etoposide and staurosporine, whereas Bak/
Bax-deﬁcient cells generally were resistant to all these treatments.
This may be due to a defective ER-stress response caused by im-
paired IRE1α activation, and to increased pro-apoptotic signaling
caused by increased JNK activation and Bim upregulation in Bok-
deﬁcient cells.
Recent evidence has emerged that Bok binds to IP3Rs and controls
their proteolytic degradation [214]. This ﬁnding is consistent with the
proposed role of Bok upstream of Bak/Bax [283] and with the failure
of Bok to directly associatewith any of the Bcl-2-familymembers. Strik-
ingly, IP3Rs seem to serve as the major cellular harbor for Bok by a
strong, constitutive interaction. Although all three IP3R isoforms can
interact with Bok, preferential binding partners of Bok are IP3R1 and
IP3R2 (Fig. 3). At the molecular level, Bok binds to IP3Rs via its N-
terminal Bcl-2 homology 4 domain (BH4) to a highly charged region
of the IP3R1 covering residues 1895–1903 (a.a. sequence PSRKKAKEP)
located in the cytosolic regulatory domain of the IP3R. This sequence
was strongly conserved among IP3R1 proteins from different species
and not conserved among other IP3R isoforms. It was proposed that a
sequence with a similar charge distribution is present in IP3R2
(PRMRVRDS), which is also conserved among different species. Bok
binding to IP3R1 seemed to control its degradation. It is well established
that stimulated cells down-regulate IP3Rs via a process that involves
poly-ubiquitination and proteasomal degradation [285,286]. Cells
exposed to chronic IP3R activation showed a concomitant decline in
both Bok and IP3R levels, whereas other Bcl-2-family members
remained unaltered. Thus, it seems that IP3R/Bok complexes are degrad-
ed as a “combined unit” [214]. In in vitro cleavage experiments, it
appeared that IP3Rs from Bok−/− cells were more susceptible to cleav-
age by chymotrypsin. This was consistent with in cellulo experiments
demonstrating that caspase 3-mediated cleavage of IP3R1 was more
readily observed in Bok−/− cells than in wild-type cells upon exposure
to staurosporine. Althoughwild-typeMEF and Bok−/−MEF cells display
very similar IICR properties, it has to be noted that differences in overall
IP3R-expression levels between both cell lines could complicate such an
analysis. In any case, the recruitment of Bok to the IP3R and concomitant
interference with its proteolytic cleavage during apoptosis is very
intriguing and could be a novel mechanism by which IP3R levels are
regulated during apoptosis. These ﬁndingsmight also have implications
for human cancers, since high-resolution analyses of somatic copy-
number alterations from more than 3000 cancer specimens revealed
the loss of Bok as a signiﬁcant alteration [287].
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4.2.1. PKB/Akt-signaling cascade
As discussed in Section 2.1.6, PKB/Akt, a known pro-survival factor
that is activated by phosphatidylinositol 3,4,5-trisphosphate [288],
phosphorylates all three IP3R isoforms in normal, dividing cells
(Fig. 3). This process is stimulated by growth factors [111,112]. For
IP3R1, phosphorylation by PKB/Akt occurred at S2681, although IP3Rs
defective in undergoing PKB/Akt phosphorylation or mimicking consti-
tutive PKB/Akt phosphorylation displayed similar IICR properties [111].
Yet, follow-up work revealed that PKB-mediated phosphorylation of
IP3R1 dictated the cellular susceptibility to apoptotic stimuli with
phospho-dead IP3R1S2681A-expressing cells being more sensitive to cell
death than phospho-mimetic IP3R1S2681E-expressing cells [112].
The role of PKB/Akt in suppressing “toxic” IP3R activity has been re-
lated to IP3R3 [289]. PKB/Akt was much more potent in protecting cells
expressing high IP3R3 levels (like COS cells) than cells expressing high
IP3R1 levels (like SH-SY5Y cells).While PKB/Akt poorly protected native
SH-SY5Y cells against arachidonic acid-induced apoptosis, it became
very effective to protect SH-SY5Y cells ectopically expressing IP3R3.
Moreover, the phosphorylation of IP3Rs by PKB/Akt may also depend
on the cellular context, including the [Ca2+]cyt. For instance, IP3R phos-
phorylation by PKB/Akt was shown to be stimulated in the presence of
Ca2+. As stated above (Section 2.1.5), the mechanism may involve
Ca2+-dependent changes in IP3R conformation, thereby enhancing
complex formation between IP3Rs and PKB/Akt and/or by increasing
the accessibility of the PKB-phosphorylation site of the IP3R [113].
Further studies revealed that the complex between IP3R3 and PKB/Akt
is regulated by protein phosphatase 2A (PP2A) and by the tumor sup-
pressor promyelocytic-leukemia (PML) protein [290,291]. The latter
promotes the recruitment of PP2A to the IP3R3, thereby counteracting
PKB/Akt activity and suppressing PKB/Akt-mediated phosphorylation
of IP3R3. The PKB/Akt-phosphorylation status and pro-apoptotic prop-
erties of the IP3R3 might be dynamically regulated and inﬂuenced by
the PML status of the cell, since in the presence of PML, IP3R3 mediates
Ca2+ ﬂux into the mitochondria and thus apoptosis will be promoted.
Altered or lost PML function and expression due to genomic transloca-
tions or mutations, as it has been observed in a large number of
human cancers including hematological malignancies and solid tumors
(as reviewed in [292]), could compromise the pro-apoptotic Ca2+
signaling through suppressed IP3R3 function and suppressed ER-
mitochondrial Ca2+ transfer. This mechanismmay therefore contribute
to the oncogenic properties of PML-deﬁcient cancer cells [293,294].
Phosphatase and tensin homolog deleted on chromosome 10
(PTEN) is very well known as a negative regulator of PKB/Akt signaling
by acting as a lipid phosphatase counteracting the accumulation of the
lipid second messenger phosphatidylinositol 3,4,5-trisphosphate and
thereby preventing the phosphorylation and activation of PKB/Akt
[295,296]. Evidence has now emerged that PTEN at the MAMs can
directly reduce IP3R3 phosphorylation by PKB/Akt by a protein-
phosphatase activity, thereby promotingCa2+ transfer to themitochon-
dria [297]. In addition to this, ER-localized PTEN may also increase the
tethering between the ER and the mitochondria.
4.2.2. Anti-apoptotic Bcl-2-family members
Anti-apoptotic Bcl-2-family members, including Bcl-2, Bcl-Xl and
Mcl-1, have been implicated in binding to and regulating IP3R channels
(Fig. 3) [205,298]. Bcl-2 was shown to form endogenous complexes
with all three IP3R isoforms and its overexpression in immature T cells
with very low endogenous Bcl-2 levels, resulted in a reduced anti-
CD3-induced IICR [299]. In follow-up work, it became clear that the
IP3R-inhibitory properties of Bcl-2 were dependent on the strength
of the T cell-receptor activation [300]. Bcl-2 mainly inhibited global
Ca2+ transients provoked byhigh concentrations of anti-CD3 and there-
fore strong T cell-receptor activation, associated with pro-apoptotic
Ca2+-signaling events, but not Ca2+ oscillations triggered by lowconcentrations of anti-CD3 and thus weak T cell-receptor activation, as-
sociated with pro-survival Ca2+-signaling events. A detailed molecular
study revealed a 20 a.a. sequence in the center of the regulatory domain
of the IP3R (a.a. 1389–1408 of mouse IP3R1) as the target for anti-
apoptotic Bcl-2 [301]. An IP3R1-derived peptide (IDP) covering this
site could disrupt endogenous IP3R/Bcl-2–protein complexes. As a con-
sequence, a cell-permeable version of this peptide (TAT-IDP) reversed
Bcl-2's inhibitory action on the IP3R, thereby promoting IICR and subse-
quent apoptotic cell death induced by high concentrations of anti-CD3
in T cells. Sequence analysis of IDP revealed that it is conserved among
the various IP3R isoforms in different species, correlating with the
original observations that Bcl-2 can form endogenous complexes with
all three IP3R isoforms [279,299]. The BH4 domain (a.a. 6–30) of Bcl-2
was found to be necessary and sufﬁcient for binding to and inhibiting
IP3Rs [302]. A synthetic BH4-domain peptide could interact with the
central, modulatory domain of all three IP3R isoforms thereby suppress-
ing IICR and apoptosis. Further structural studies in which theα-helical
structure of the BH4–Bcl-2 peptide was disrupted by mutating back-
bone residues into G, revealed the critical role of the alpha-helical prop-
erties of this domain for binding and inhibiting IP3Rs, and for protecting
against Ca2+-dependent apoptotic stimuli like staurosporine [303]. In
addition, the BH4 domain of Bcl-Xl failed to bind and inhibit IP3Rs
[279], which might be attributed to a single amino acid difference
between both domains. A single amino acid change of K17 into D in
BH4–Bcl-2, thereby mimicking BH4–Bcl-Xl, was sufﬁcient to abolish
its ability to bind and inhibit IP3Rs. In contrast, mutating D11 into K in
BH4–Bcl-Xl, thereby mimicking BH4–Bcl-2, induced IP3R binding and
inhibition. Hence, it seems that electrostatic interactions are critical for
complex formation between IP3Rs and the BH4 domain of Bcl-2 [304].
This has important biological consequences for the anti-apoptotic prop-
erties of Bcl-2 and Bcl-Xl, suggesting distinct cellular targets for their
BH4domains [279]. Nevertheless, it should bepointed out that although
Bcl-2 and Bcl-Xl seem to differ at the level of their BH4 domain, full-size
Bcl-Xl was able to bind to the modulatory domain of IP3R1, but with a
lower afﬁnity than the full-size Bcl-2 [305]. These fundamental insights
in IP3R/Bcl-2-complex formation and peptide tools that target the BH4
domain of Bcl-2 but not that of Bcl-Xl have been exploited to trigger
pro-apoptotic Ca2+ signaling in Bcl-2-dependent cancer cells, like
chronic lymphocytic leukemia [306] and diffuse large B-cell lymphoma
[307]. A stabilized, protease-resistant version of the cell-permeable
TAT-IDP (TAT-IDPS) seemed very effective to trigger apoptosis in prima-
ry cells obtained from chronic lymphocytic leukemia patients but not in
lymphocytes isolated from healthy donors [306]. TAT-IDPS-triggered
cell death was associated with the occurrence of excessive Ca2+ spikes
and sustained [Ca2+]cyt elevations, and depended on the activity of
the IP3R. Further mechanistic insights were provided from a collection
of diffuse large B-cell lymphoma cancer cells in which the TAT-IDPS-
induced [Ca2+]cyt rise and cell death correlated with the IP3R2-
expression levels, but not with IP3R1-, IP3R3- or total IP3R-expression
levels [307]. As it was already mentioned in Section 2.1.1, IP3R2 and
IP3R3 display the highest and lowest sensitivity to IP3 respectively. Can-
cer cells with high IP3R2 levelswere very sensitive to TAT-IDPS, whereas
cancer cells with low IP3R2 levels were almost completely resistant to
TAT-IDPS treatment. Furthermore, IP3R/Bcl-2-complex formation was
more prominent in TAT-IDPS-sensitive cancer cells than in TAT-IDPS-
resistant cancer cells. Therefore, we propose that cancer cells expressing
high IP3R2 levels aremore “addicted” to the presence of Bcl-2 at the IP3R
and at the ER Ca2+ stores than cancer cells expressing low IP3R2 levels.
Clearly, the mechanisms that control the differential IP3R isoform-
expression proﬁle in cancer cells and that contribute to the resistance
of cancer cells to TAT-IDPS should be further examined.
Despite the observed differences between Bcl-2 and Bcl-Xl at the
level of their BH4 domain, there is clear evidence that Bcl-Xl can also di-
rectly bind and modulate IP3Rs [190,206]. Bcl-Xl binding was proposed
to occur at the C-terminal domain in the proximity of the Ca2+ channel-
pore domain of the IP3R [190] with a critical role for the 6th
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and Bcl-Xl showed equal binding afﬁnity for the C-terminus of the
IP3R containing the 6th transmembrane domain [305]. Bcl-Xl binding
to the IP3R sensitized the channel in response to a low [IP3], thereby
promoting either spontaneous or low [agonist] induced pro-survival
Ca2+ oscillations and improving mitochondrial bio-energetics [190,
206]. The positive effects of Bcl-Xl on Ca2+ oscillations were observed
in DT40-TKO cells expressing IP3R1, IP3R2 or IP3R3 but not in regular
DT40-TKO cells, nor in mock DT40-TKO cells [206]. Consistent with
these effects, Bcl-Xl-mediated protection against apoptosis occurred
mainly in IP3R-expressing DT40-TKO cells, while no protective effect
of Bcl-Xl was observed in mock-expressing DT40-TKO cells. All three
IP3R isoform were able to mediate the Bcl-Xl protective function.
Furthermechanistic evidence on the enhanced efﬁciency of the channel
opening in response to IP3 suggested a possible role of two BH3-
domain-like structures in the C-terminal tail of IP3R in the binding of
Bcl-Xl [309], but this ought to be further investigated.
A very recent study revealed a potential mechanism for suppression
of the Bcl-Xl-dependent sensitization of the IP3R via binding of a
phosphorylated K-RAS isoform to the receptor. The authors proposed
a model for indirect interaction between Bcl-Xl and phosphorylated
K-RAS4B in which both proteins target the C-terminus of the IP3R
and the formation of this three-molecular complex counteracted
Bcl-Xl's sensitizing effects on IP3R single-channel activity and subse-
quent basal Ca2+ signaling in the mitochondria [310]. Only a
phospho-mimetic, but not a phospho-dead or wild-type K-RAS vari-
ant was able to block Bcl-Xl's effect on IP3Rs and could lower basal
mitochondrial Ca2+ signaling, needed for respiration. Consistent
with this, ectopic expression of phospho-mimetic K-RAS4B resulted in
autophagy induction in a Bcl-Xl-dependent manner and subsequent
toxicity [310].
Finally, similar to Bcl-2 and Bcl-Xl, Mcl-1 also binds to and regulates
IP3Rs by targeting the C-terminal part, containing the 6th transmem-
brane domain of the IP3R, thereby promoting IP3R-mediated pro-
survival Ca2+ oscillations [308].
4.2.3. Beclin 1
Beclin 1 (ATG6) is a protein essential for the execution of the canon-
ical mTOR-controlled autophagy pathway [311]. Beclin 1 is inhibited by
anti-apoptotic Bcl-2 [312,313], but phosphorylation events in Beclin 1
and Bcl-2 can disrupt their interaction and can initiate autophagy by
recruiting the Vps34 complex [314–317]. IP3Rs contribute to the nega-
tive regulation of autophagy by recruiting Beclin 1 and thus limiting
the amount of “free” Beclin 1 available for autophagy induction
[318–320]. Binding of Beclin 1 to IP3Rs seemed to occur via the IP3-
binding domain. Both for IP3R1 and IP3R3, the primary target for Beclin
1 seemed to be the suppressor domain (a.a. 1–225) (Fig. 3), but also
the IP3-binding core (a.a. 226–604) showed a speciﬁc but weaker inter-
action with Beclin 1. It was proposed that IP3R inhibition by pharmaco-
logical tools like xestospongin B or genetic approaches like the use of
DT40-TKO cells results in the release of Beclin 1 and enhanced basal
autophagy through an AMPK-dependent mechanism correlating with
the fact that basal IP3R activity suppresses autophagy [174]. Basal IP3R
activitymay fuel Ca2+ into themitochondria, thereby promoting the ac-
tivity of Ca2+-dependent enzymes of the Krebs cycle and subsequent
ATP production [174,225]. An independent study showed that the role
of the IP3R in controlling the basal autophagic ﬂux critically depended
on its Ca2+-ﬂux properties, since both DT40-TKO cells and DT40-TKO
cells expressing a pore-dead mutant of IP3R1 displayed elevated LC3-II
levels, a marker for autophagy [321]. In this study, however, the mech-
anism by which IP3Rs controlled basal autophagy seemed independent
of changes in AMPK and PKB/Akt activity or of Beclin 1/Bcl-2- and Beclin
1/Vps34-complex formation, but was attributed to decreased basal
mTOR activity in DT40-TKO cells [321]. These observations seem to
indicate a role for basal IP3R-mediated Ca2+ ﬂuxes in sustaining basal
mTOR activity, but the mechanisms ought to be further scrutinized.In addition to this complexity, there seems to be a dual role for IP3Rs
and Ca2+ signaling in controlling autophagy [317,322]. For instance,
chronic elevations of the [Ca2+]cyt have been shown to activate the
Ca2+/calmodulin-dependent kinase kinase β, an upstream activator of
AMPK [323].While on the onehand IP3Rs clearly suppress basal autoph-
agy, IP3R activity and sensitization, on the other hand, were critical for
driving mTOR-controlled autophagy induced by nutrient starvation or
by rapamycin treatment [324,325]. Recombinantly expressed and puri-
ﬁed Beclin 1 was able to sensitize IP3R function. In contrast, knocking
down Beclin 1 prevented IP3R sensitization associated with nutrient
starvation. This seemed independent of Beclin 1's essential role in
autophagy, since other essential autophagy-dependent gene products
that act downstream of Beclin 1 (like ATG5) were not able to prevent
IP3R sensitization.
4.2.4. G-protein-coupled receptor kinase-interacting proteins 1 and 2
(GIT1 and GIT2)
GIT1 and GIT2 are ubiquitously expressed multi-domain proteins
containing an N-terminal ADP ribosylation factor GTPase-activating
protein domain, three ankyrin repeats, a spa2-homology domain, a
coiled-coil domain and a C-terminal paxillin-binding site (as reviewed
in [326]). Through a complex network of protein interactions, GIT1
and GIT2 control cytoskeletal dynamics, receptor internalization and
membrane trafﬁcking [326]. As such, GIT proteins have been implicated
in cell migration and tumor invasiveness [327], chemotactic responses
[328] and platelet activation by thrombin [329]. GIT1 has also been im-
plicated in Ca2+ signaling by interacting with the SH2 domain of PLCγ
[330]. The binding of GIT1 to PLCγ was essential for proper PLCγ
phosphorylation and activation. Further work revealed another role
for GIT1 andGIT2 in Ca2+ signaling and cell death bydirectly interacting
with the IP3R. GIT1 and GIT2 were able to bind to all three IP3R isoforms
[331]. The binding of GIT1 and GIT2 to IP3Rs occurred via the C-terminal
tail of the receptor. Two regions were identiﬁed as the GIT1/GIT2-
binding site in the last 50 amino acids of IP3R1 (a.a. 2700–2710 and
a.a. 2735–2749) and IP3R2 (a.a. 2652–2662 and a.a. 2687–2701) and
in the last 44 amino acids of IP3R3 (a.a. 2627–2637 and a.a. 2664–
2670) (Fig. 3) [331]. The binding of the GIT proteins to the C-terminus
of the IP3Rs occurred via their second IQ-like motif and was enhanced
in the presence of an increased [Ca2+]cyt. As a consequence, cells
exposed to ATP or thapsigargin displayed enhanced IP3R/GIT-complex
formation. Recombinantly expressed and puriﬁed GIT proteins, but
not GITL712A that fails to bind IP3Rs, are able to suppress IICR from cere-
bellar microsomes and to inhibit agonist-induced Ca2+ release without
affecting the ER Ca2+-store content, respectively. On the other hand,
GIT1 and GIT2 knock down increased agonist-induced Ca2+ signaling.
Knocking down GIT1 was associated with an increase in spontaneous
apoptotic cell death and resulted in hypersensitivity towards apoptotic
stimuli like staurosporine, which could be suppressed using IP3R inhib-
itors. In contrast, overexpressing GIT1 protected against staurosporine-
induced apoptosis. This was abolished for the binding mutant GITL712A,
indicating that GIT1 binding to IP3Rs was essential for the protective
effect. While all three IP3R isoforms are targets of the GIT proteins,
complex formation seemed more efﬁcient with IP3R1 and IP3R2.
Hence, the inhibition of IP3R1 and IP3R2 by the GIT proteins may be
more critical to prevent pro-apoptotic Ca2+-signaling events, consistent
with their ability to produce long-lasting and excessive Ca2+ oscilla-
tions [23]. Although low-level Ca2+ oscillations are typically associated
with a pro-survival outcome and improved mitochondrial bio-
energetics [174,226], excessive Ca2+ oscillations may result in cell
death [332].
5. ROS and thiol modiﬁcations of IP3Rs
Oxidative stress and the generation of ROS modulate cell survival
and cell death, in particular during ischemia/reperfusion injury and in-
ﬂammatory responses [333]. ROS can modulate IP3 signaling and IP3Rs
2176 H. Ivanova et al. / Biochimica et Biophysica Acta 1843 (2014) 2164–2183by themodiﬁcation of cysteinyl residues, potentially in an IP3R isoform-
dependent manner [334].
A clear role for IP3R1-mediated Ca2+ release in endothelial-cell
death upon ROS produced by lipo-polysaccharide-activated macro-
phages has been described [335]. Paracrine superoxide (O2·−) signaling
led to the activation of PLC, triggering IICR. Ectopic expression of IP3R1
was sufﬁcient to restore O2·− induced Ca2+ signaling in DT40-TKO
cells, but the relevance of the other IP3R isoforms to respond to O2·−
generated signals was not investigated. O2·− induced [Ca2+]cyt rises
were also observed in the mitochondria resulting in mitochondrial de-
polarization. As a consequence, extracellularly generated O2·− resulted
in the activation of caspase 9 and caspase 3 through a mitochondria-
dependent pathway. In a very recent study combining intact and
permeabilized cell systems [336], it was shown that O2·− produced
from xanthine by xanthine oxidase enhanced and/or triggered Ca2+-
signaling events in different cell models by directly targeting IP3Rs
and increasing their sensitivity to submaximal IP3 concentrations. Inter-
estingly, the potentiating effect of O2·− on IICR seemed much more
pronounced in the mitochondria than in the cytosol, highlighting the
importance of O2·− and IP3Rs for local ER-mitochondrial Ca2+ transfer.
Exploiting the DT40-TKO cells, it was shown that the O2·− induced
Ca2+ release was severely compromised in cells lacking all three IP3R
isoform or lacking both IP3R1 and IP3R2 (and thus only expressing the
chicken IP3R3 isoform). These data indicate that the chicken IP3R1 and
IP3R2 isoforms are sensitive to O2·−, while the chicken IP3R3 isoform
is resistant. However, it is important to note that the sensitizing effect
of O2·− on IP3Rs is not only isoform speciﬁc but also species, since the
rat IP3R3 isoform ectopically expressed in DT40-TKO cells was sensi-
tized by O2·−. The reason for this difference between the chicken and
rat IP3R3 was attributed to a potential difference in accessibility of evo-
lutionary conserved cysteine residues.
Furthermore, oxidative stress has been shown to inﬂuence the
expression of IP3R isoforms. In neuronal cells, it was shown that sub-
lethal tert-butyl hydroperoxide-mediated oxidative stress resulted in
increased nuclear Ca2+-signaling events, which could be completely
prevented by using an IP3R inhibitor [337]. At the molecular level, this
enhanced Ca2+ signalingwas associatedwith an increase in the expres-
sion level of IP3R2 at both the mRNA and protein level, while IP3R1 and
IP3R3 channels or other intracellular Ca2+-release mechanisms, like the
RyRs and the polycystins, remained unaffected.
Another form of thiol modiﬁcation of proteins occurs in response
to H2S signaling, which causes sulfhydration of proteins, thereby
converting the SH group of cysteine into an SSH group [338,339]. Endog-
enous H2S is produced from L-cysteine by cystathionine β-synthase and
cystathionine γ-lyase and functions as a physiological vasodilator and
regulator of the blood pressure. The H2S-producing activity of cystathio-
nine γ-lyase requires cytosolic Ca2+ and calmodulin, which forms a
complex with the enzyme [340].
Recently, chemicals that act either as slow or fast H2S donors
(GYY4137 and NaSH, respectively) were found to trigger an increase
in [Ca2+]cyt and a decrease in the [Ca2+]ER of mammalian cells [341].
The depletion of the ER Ca2+ stores by these H2S donors was associated
with ER stress. These events could be partially rescued by inhibiting the
IP3Rs. The prolonged exposure of the cells to slow H2S donors was asso-
ciated with an increase in the IP3R1- and IP3R2-expression levels, while
the IP3R3-expression levels remained unaltered. These changes in IP3R1
and IP3R2 expression were dependent on thiol modiﬁcations, since re-
ducing agents like dithiothreitol could counteract this upregulation.
These events were also associated with increased apoptosis and
mitochondrial depolarization. Importantly, increased IP3R1- and
IP3R2-mediated signaling and expression levels were responsible for
GYY4137-induced cell death, since both IP3R inhibitors aswell as silenc-
ing either IP3R1 or IP3R2 channels suppressed GYY4137-induced cell
death. Altered IP3R-isoform expression in combination with increased
IP3 signaling may contribute to H2S-induced ER stress and concomitant
cell death. The latter phenomenon has been observed in insulin-secreting β cells exposed to H2S [342] and may be very relevant for pa-
thologies like diabetes, as pancreatic islets of diabetic mice have been
associated with an overproduction of endogenous H2S and a concomi-
tant suppression of insulin release [343]. In this context, H2S-induced
ER stress together with an activation of KATP channels may result in de-
fective insulin release from β cells [344]. Yet, the role of altered IP3R
isoform-expression levels during pathological H2S signaling in pancre-
atic β cells under diabetic conditions ought to be further established.
However, the effect of H2S on IP3Rs may be more complex and may
not only be stimulatory. For instance, in airway smoothmuscle, H2S do-
nors reversibly inhibited IICR in response to intracellular IP3 uncaging
and physiological stimuli acting through IP3Rs like acetylcholine [345].
Correlating with these effects several H2S donors counteracted contrac-
tions induced by IP3 uncaging and caused relaxation in acetylcholine
pre-treated and thus pre-constricted airway smooth-muscle cells.
These effects could be mimicked by reducing agents and inhibited by
oxidizing agents [345]. The reasons for these opposite effects of H2S
on IP3R function are not clear, but could be dependent on differences
in IP3R isoform-expression levels and differences in H2S concentrations
and exposure times.
6. Conclusion
The IP3R has emerged as a cellular hub integrating many signaling
pathways that control cell fate. It becomes increasingly clear that the
various IP3R isoforms can be involved in these functions. As these iso-
forms have slightly different functional properties this allows a ﬁne
tuning in the cellular responses, which in some cases critically affects
the ﬁnal cellular decision for proliferation, autophagy or cell death. For
a number of basic cellular regulators including IP3 itself, Ca2+ and
Ca2+-binding proteins, ATP and thiol-group modulation, there are sev-
eral reports about isoform-speciﬁc differences. Also with respect to the
interactionwith regulatory proteins and phosphorylation by protein ki-
nases, isoform speciﬁcity has been described. A less well documented
matter concerns the isoform speciﬁcity of the cellular and subcellular
localization of IP3Rs, for which no deﬁned pattern is available. This is
particularly relevant with respect to the localization in the MAMs, mi-
crodomains responsible for a privileged transfer between the ER and
the mitochondria. As an efﬁcient transfer of Ca2+ to the mitochondria
is of utmost importance for survival, autophagy or cell death, one can
expect that the subtype and regulation of the isoform present in the
MAMs is crucial for determining cell fate. Although IP3R3 has been re-
ported to be associatedwith theMAMs [152,164], it is not clearwhether
this is a universal property of all cell types, particularly cancer cells. In
this respect, not only IP3R-isoform localization and intrinsic properties,
but also differential regulation of different isoforms as for example by
PKB/Akt, may be crucial to understand the sensitivity of different cancer
cells to such treatments.
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